Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360250
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-07
Brief Title:
Safety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 B86 Injection Combination Formulation
Sponsor:
Organization:
Changchun BCHT Biotechnology Co